Received Apr 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT879MA | — |
patient was given vaccine with this post-excursion with no AE; Initial information received on 01-Apr-2026 regarding an unsolicited valid non-serious case received from a healthcare professional (HCP). This case involves a patient of unknown age and unknown gender who received influenza USP trival A-B subvirion no preservative vaccine (Fluzone NP) with this post-excursion with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. On an unknown date, the patient received a dose of unknown frequency of influenza USP trival A-B subvirion no preservative vaccine [Fluzone] suspension for injection (batch/lot number: UT879MA, expiry date: 30-Jun-2026) (strength: unknown) via unknown route in an unknown administration site for influenza (influenza immunization) post excursion with no adverse event (poor quality product administered, onset: unknown, latency: same day). Action taken: not applicable.
Comments: NONE